FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2895849854> ?p ?o ?g. }

• W2895849854 endingPage "425" @default.
• W2895849854 startingPage "413" @default.
• W2895849854 abstract "Tumor-infiltrating lymphocytes (TIL)-therapy in advanced melanoma is an advanced therapy medicinal product (ATMP) which, despite promising results, has not been implemented widely. In a European setting, TIL-therapy has been in use since 2011 and is currently being evaluated in a randomized controlled trial. As clinical implementation of ATMPs is challenging, this study aims to evaluate early application of TIL-therapy, through the application of a constructive technology assessment (CTA). First the literature on ATMP barriers and facilitators in clinical translation was summarized. Subsequently, application of TIL-therapy was evaluated through semistructured interviews with 26 stakeholders according to 6 CTA domains: clinical, economic, patient-related, organizational, technical, and future. In addition, treatment costs were estimated. A number of barriers to clinical translation were identified in the literature, including: inadequate financial support, lack of regulatory knowledge, risks in using live tissues, and the complex path to market approval. Innovative reimbursement procedures could particularly facilitate translation. The CTA survey of TIL-therapy acknowledged these barriers, and revealed the following facilitators: the expected effectiveness resulting in institutional support for an internal pilot, the results of which led to the inclusion of TIL-therapy in a national coverage with evidence development program, the availability of an in-house pharmacist, quality assurance expertise and a TIL-skilled technician. Institutional and national implementation of TIL-therapy remains complex. The promising clinical effectiveness is expected to facilitate the adoption of TIL-therapy, especially when validated through a randomized controlled trial. Innovative and conditional reimbursement procedures, together with the organization of knowledge transfer, could support and improve clinical translation of TIL and ATMPs." @default.
• W2895849854 created "2018-10-26" @default.
• W2895849854 creator A5017136846 @default.
• W2895849854 creator A5021312666 @default.
• W2895849854 creator A5040943305 @default.
• W2895849854 creator A5060997761 @default.
• W2895849854 creator A5072317673 @default.
• W2895849854 creator A5089235633 @default.
• W2895849854 date "2018-11-01" @default.
• W2895849854 modified "2023-10-03" @default.
• W2895849854 title "Treatment With Tumor-infiltrating Lymphocytes in Advanced Melanoma: Evaluation of Early Clinical Implementation of an Advanced Therapy Medicinal Product" @default.
• W2895849854 cites W1883154993 @default.
• W2895849854 cites W1933724083 @default.
• W2895849854 cites W1967980758 @default.
• W2895849854 cites W1986215428 @default.
• W2895849854 cites W2010034728 @default.
• W2895849854 cites W2049350239 @default.
• W2895849854 cites W2064601736 @default.
• W2895849854 cites W2071741089 @default.
• W2895849854 cites W2082902034 @default.
• W2895849854 cites W2111933437 @default.
• W2895849854 cites W2114481318 @default.
• W2895849854 cites W2126243421 @default.
• W2895849854 cites W2132923173 @default.
• W2895849854 cites W2138657325 @default.
• W2895849854 cites W2142583303 @default.
• W2895849854 cites W2147233604 @default.
• W2895849854 cites W2155825917 @default.
• W2895849854 cites W2163954835 @default.
• W2895849854 cites W2166662937 @default.
• W2895849854 cites W2172957160 @default.
• W2895849854 cites W2216069979 @default.
• W2895849854 cites W2309691699 @default.
• W2895849854 cites W2318903681 @default.
• W2895849854 cites W2324899967 @default.
• W2895849854 cites W2335365056 @default.
• W2895849854 cites W2463718837 @default.
• W2895849854 cites W2495969413 @default.
• W2895849854 cites W2514137348 @default.
• W2895849854 cites W2515234975 @default.
• W2895849854 cites W2533320757 @default.
• W2895849854 cites W2543442644 @default.
• W2895849854 cites W2559346232 @default.
• W2895849854 cites W2572174216 @default.
• W2895849854 cites W2573321206 @default.
• W2895849854 cites W2573498766 @default.
• W2895849854 cites W2591365367 @default.
• W2895849854 cites W2592735801 @default.
• W2895849854 cites W2607056793 @default.
• W2895849854 cites W2614372347 @default.
• W2895849854 cites W2790706219 @default.
• W2895849854 cites W2891313372 @default.
• W2895849854 cites W2071579845 @default.
• W2895849854 doi "https://doi.org/10.1097/cji.0000000000000245" @default.
• W2895849854 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6200372" @default.
• W2895849854 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30300260" @default.
• W2895849854 hasPublicationYear "2018" @default.
• W2895849854 type Work @default.
• W2895849854 sameAs 2895849854 @default.
• W2895849854 citedByCount "9" @default.
• W2895849854 countsByYear W28958498542019 @default.
• W2895849854 countsByYear W28958498542020 @default.
• W2895849854 countsByYear W28958498542021 @default.
• W2895849854 countsByYear W28958498542022 @default.
• W2895849854 countsByYear W28958498542023 @default.
• W2895849854 crossrefType "journal-article" @default.
• W2895849854 hasAuthorship W2895849854A5017136846 @default.
• W2895849854 hasAuthorship W2895849854A5021312666 @default.
• W2895849854 hasAuthorship W2895849854A5040943305 @default.
• W2895849854 hasAuthorship W2895849854A5060997761 @default.
• W2895849854 hasAuthorship W2895849854A5072317673 @default.
• W2895849854 hasAuthorship W2895849854A5089235633 @default.
• W2895849854 hasBestOaLocation W28958498542 @default.
• W2895849854 hasConcept C141071460 @default.
• W2895849854 hasConcept C142724271 @default.
• W2895849854 hasConcept C160735492 @default.
• W2895849854 hasConcept C168563851 @default.
• W2895849854 hasConcept C17744445 @default.
• W2895849854 hasConcept C19527891 @default.
• W2895849854 hasConcept C199539241 @default.
• W2895849854 hasConcept C2777921204 @default.
• W2895849854 hasConcept C2779703844 @default.
• W2895849854 hasConcept C41008148 @default.
• W2895849854 hasConcept C535046627 @default.
• W2895849854 hasConcept C56739046 @default.
• W2895849854 hasConcept C71924100 @default.
• W2895849854 hasConceptScore W2895849854C141071460 @default.
• W2895849854 hasConceptScore W2895849854C142724271 @default.
• W2895849854 hasConceptScore W2895849854C160735492 @default.
• W2895849854 hasConceptScore W2895849854C168563851 @default.
• W2895849854 hasConceptScore W2895849854C17744445 @default.
• W2895849854 hasConceptScore W2895849854C19527891 @default.
• W2895849854 hasConceptScore W2895849854C199539241 @default.
• W2895849854 hasConceptScore W2895849854C2777921204 @default.
• W2895849854 hasConceptScore W2895849854C2779703844 @default.
• W2895849854 hasConceptScore W2895849854C41008148 @default.
• W2895849854 hasConceptScore W2895849854C535046627 @default.
• W2895849854 hasConceptScore W2895849854C56739046 @default.

• next